PASADENA, Calif. (AP) _ Arrowhead Research Corp. (ARWR) on Tuesday reported a loss of $15.6 million in its fiscal third quarter.
On a per-share basis, the Pasadena, California-based company said it had a loss of 18 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The drug developer posted revenue of $727,400 in the period. Its adjusted revenue was $727,000, which also beat Street forecasts. Four analysts surveyed by Zacks expected $620,000.
Arrowhead Research shares have more than quadrupled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $15.04, increasing sevenfold in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARWR at https://www.zacks.com/ap/ARWR